Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1990-1-9
pubmed:abstractText
We measured isotype-specific human antibodies directed against Campylobacter jejuni native flagellin and a synthetic peptide derived from the N-terminal amino acid sequence of the protein by using a microdilution enzyme-linked immunosorbent assay (ELISA). Serum samples from patients with gastrointestinal infection caused by C. jejuni (n = 20) and control samples (number from normal subjects = 20; number from patients with diarrhea other than campylobacter = 20) were tested in this assay. Serum specimens from patients with campylobacter infection showed statistically significant higher isotype-specific antiflagellin antibody titers than control samples did. Detection of immunoglobulin G (IgG) antibodies was less specific (70%) than detection of either IgA or IgM antibodies in infected patients (95%). The sensitivity of testing for any of the isotypes ranged from 64 to 100% in acute-phase serum specimens and 85 to 95% in convalescent-phase serum specimens. An ELISA with an N-terminal synthetic peptide derived from the flagellin protein as antigen was not sensitive (60%) for detecting campylobacter infection but was very specific (97.5%). In conclusion, detection of serum IgA or IgM against C. jejuni flagellin may be a useful marker of infection. Although the N-terminal synthetic peptide was antigenic in a few patients with infection and showed good specificity in the ELISA, additional amino acid sequences with better sensitivity for detecting infection need to be identified.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-2444578, http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-2444623, http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-2578478, http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-2578479, http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-2873103, http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-3137040, http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-3611318, http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-4056739, http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-6715034, http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-6885981, http://linkedlifedata.com/resource/pubmed/commentcorrection/2584372-708370
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2195-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Human antibody response to Campylobacter jejuni flagellin protein and a synthetic N-terminal flagellin peptide.
pubmed:affiliation
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-4283.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.